Skip to nav Skip to content


A woman, looking thoughtful, having a cup of coffee

The general invasive ductal carcinoma survival rate is a helpful benchmark that provides physicians with a uniform way to describe and discuss patient outcomes. Of course, a survival rate is merely an average of the experiences of a large group of people that occurred several years ago. No patient can ever be considered “average,” and many patients experience much better outcomes than the general survival rate would suggest. As new and better treatments are being developed and put into use, the survival rate is continually improving, and individuals who are diagnosed with breast cancer today are living longer and higher-quality lives than those who were diagnosed even only a few years ago. As such, the overall survival rate is not a reliable indicator of any specific patient’s prognosis.

Many individual factors can influence the invasive ductal carcinoma survival rate, including:

  • Whether the cancer is newly diagnosed or a recurrence
  • The stage of the cancer at the time of diagnosis, and whether it is confined to a breast or has spread to lymph nodes and other tissues and organs
  • The hormone-receptor status of the cancer
  • The HER2 status of the cancer
  • The growth rate of the cancer cells
  • The cancer’s response to treatment
  • A patient’s age, overall health and menopausal status (if female)

At Moffitt Cancer Center, the fellowship-trained surgeons, oncologists, researchers and other members of the multispecialty cancer team in our Don & Erika Wallace Comprehensive Breast Program are committed to continually improving our patients’ outcomes and quality of life. Our extensive cancer research spans multiple disciplines in order to provide comprehensive benefits in all aspects of breast cancer diagnosis, treatment and support. We continue to evaluate new screening techniques as well, which will help us further improve the breast cancer survival rate by diagnosing the condition as early as possible.

If you’d like to learn more about the general invasive ductal carcinoma survival rate, and how it might apply to your unique situation, the experts at Moffitt can help. Call 1-888-663-3488 or complete a new patient registration form online. No referrals are required.